VAERS 1387909
SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ389ABA
- Staat
- OH
- Alter
- 1,5
- Geschlecht
- F
- Eingang
- 10.06.2021
- Impfdatum
- 28.05.2021
- Beginn
- 28.05.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RL
Symptomtext
HCP accidentally grabbed Pentacel instead of Daptacel by mistake and administered to patient with no adverse event; Initial information regarding an unsolicited valid non-serious was received from other healthcare professional via Medical Information (Reference number- 00620295) and transmitted to Sanofi on 28-May-2021. This case involves an 18 months old female patient who was administered with a 0.5 mL dose of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL] (lot UJ389ABA and expiry date: 09-Oct-2021) via intramuscular route in the right thigh instead of DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] (lot number and expiry date were not reported) (wrong product administered) for prophylactic vaccination as administrator accidentally grabbed wrong vaccine by mistake on 28-May-2021. The patient's medical history, past medical treatments, past vaccinations and family history were not provided. Concomitant vaccinations included HEPATITIS A VACCINE (HEPATITIS A VACCINE); PNEUMOCOCCAL VACCINE (PNEUMOCOCCAL VACCINE) for Immunisation. The reporter asked if receiving the extra Ipol and ActHIB will harm the patient. Reporter also asked what side effects she should look out for. As it turned out it was also time for the ActHIB, however the next Ipol vaccine is not due until ages 4-6 years of age. They stated that Stated that a patient was given pentacel but the patient only needed the dTap. It was an actual medication error case due to wrong vaccine administered (latency: same day). At the time of reporting, the patient experienced no adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- HEPATITIS A VACCINE; PNEUMOCOCCAL VACCINE
- Allergien
- -
- Vorherige Impfungen
- -